121 related articles for article (PubMed ID: 16764644)
1. Which way forward for treatment of severe ocular inflammation?
Lightman S; McCluskey PJ
Clin Exp Ophthalmol; 2006; 34(4):293-4. PubMed ID: 16764644
[No Abstract] [Full Text] [Related]
2. Immunosuppressive therapy for ocular diseases.
Jap A; Chee SP
Curr Opin Ophthalmol; 2008 Nov; 19(6):535-40. PubMed ID: 18854699
[TBL] [Abstract][Full Text] [Related]
3. [New drugs in the treatment of noninfectious uveitis].
Cano-Parra J; Díaz-Llopis M
Arch Soc Esp Oftalmol; 2006 Dec; 81(12):671-3. PubMed ID: 17199159
[No Abstract] [Full Text] [Related]
4. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines for the management of uveitis in internal medicine].
Abad S; Sève P; Dhote R; Brézin AP
Rev Med Interne; 2009 Jun; 30(6):492-500. PubMed ID: 18824279
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
Evereklioglu C; Borlu M
Br J Ophthalmol; 2008 Aug; 92(8):1034, 1148-9. PubMed ID: 18653594
[No Abstract] [Full Text] [Related]
7. [News on therapies for uveitis].
de Smet MD
J Fr Ophtalmol; 2005 May; 28(5):556-61. PubMed ID: 15976726
[TBL] [Abstract][Full Text] [Related]
8. Infliximab and adalimumab for uveitis.
Martel JN; Esterberg E; Nagpal A; Acharya NR
Ocul Immunol Inflamm; 2012 Feb; 20(1):18-26. PubMed ID: 22324897
[TBL] [Abstract][Full Text] [Related]
9. The influence of diabetes mellitus on the management and visual outcome of patients with uveitis.
Talat L; Tomkins-Netzer O; Taylor SR; Din NM; Bar A; Isa H; Lightman S
Acta Ophthalmol; 2014 Jun; 92(4):e329-30. PubMed ID: 24314269
[No Abstract] [Full Text] [Related]
10. Biologic agents in the management of inflammatory eye diseases.
Michalova K; Lim L
Curr Allergy Asthma Rep; 2008 Jul; 8(4):339-47. PubMed ID: 18606088
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab vs. triamcinolone.
Soheilian M; Rabbanikhah Z; Ramezani A; Kiavash V; Yaseri M; Peyman GA
Ophthalmology; 2010 Apr; 117(4):855-855.e2. PubMed ID: 20346835
[No Abstract] [Full Text] [Related]
12. Triamcinolone acetonide in ocular therapeutics.
Jermak CM; Dellacroce JT; Heffez J; Peyman GA
Surv Ophthalmol; 2007; 52(5):503-22. PubMed ID: 17719372
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of infliximab on the acute attack of uveitis.
Alokaily F; Alsaleh S; Al-Balawi M; Al-Rashidi S
Saudi Med J; 2010 Jan; 31(1):82-5. PubMed ID: 20062906
[TBL] [Abstract][Full Text] [Related]
14. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
15. Biologic therapies for inflammatory eye disease.
Lim L; Suhler EB; Smith JR
Clin Exp Ophthalmol; 2006; 34(4):365-74. PubMed ID: 16764659
[TBL] [Abstract][Full Text] [Related]
16. Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96).
Onal S; Tugal-Tutkun I
Ophthalmology; 2014 Oct; 121(10):e57-8. PubMed ID: 25064722
[No Abstract] [Full Text] [Related]
17. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
[TBL] [Abstract][Full Text] [Related]
18. Re: Triamcinolone acetonide in ocular therapeutics.
Rishi P; Sharma T; Rishi E
Surv Ophthalmol; 2008; 53(2):184; author reply 184. PubMed ID: 18348883
[No Abstract] [Full Text] [Related]
19. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
Suhler EB; Smith JR; Wertheim MS; Lauer AK; Kurz DE; Pickard TD; Rosenbaum JT
Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830
[TBL] [Abstract][Full Text] [Related]
20. The role of biologic agents in the management of non-infectious uveitis.
Heo J; Sepah YJ; Yohannan J; Renner M; Akhtar A; Gregory A; Shulman M; Do DV; Nguyen QD
Expert Opin Biol Ther; 2012 Aug; 12(8):995-1008. PubMed ID: 22780091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
